文献速递胸部技术与安全CT

需体外膜肺氧合支持患者的身体成分与死亡率之间的关联

Association between body composition and mortality in patients requiring extracorporeal membrane oxygenation support.
PubMed 文献 · Clin Radiol · 2024-01-08

回顾性纳入2015年1月至2019年12月因急性呼吸衰竭接受静脉-静脉体外膜肺氧合(VV ECMO)的全部患者,用自动图像分割软件量化启动ECMO后48小时内全身CT图像上L3水平不同肌肉和脂肪区域的横截面积和平均放射密度,主要终点为启动ECMO后30天全因死亡率。189例患者中,30天生存状态与肌肉或脂肪横截面积无显著关联,但死亡者L3水平肌肉衰减(腰大肌、最长肌和腹部肌肉)显著更低;多变量分析显示腰大肌衰减是30天生存的独立预测因子(OR 0.97;95% CI 0.94至1.00;p=0.047)。结论认为腰大肌衰减降低与VV ECMO支持呼吸衰竭患者启动ECMO后30天生存结局较差相关,肌肉和脂肪区域横截面积即使校正身高和性别后也与30天生存结局无关。

要点

  • L3水平腰大肌、最长肌和腹部肌肉衰减在ECMO启动后30天内死亡者中显著更低(p<0.05)。
  • 腰大肌衰减是多变量分析中30天生存的独立预测因子(OR 0.97;95% CI 0.94至1.00;p=0.047)。
  • 肌肉或脂肪横截面积与30天生存状态无显著关联,校正身高和性别后亦然。

核心结论

  • 腰大肌衰减降低与VV ECMO支持呼吸衰竭患者启动ECMO后30天生存结局较差相关;肌肉和脂肪区域横截面积即使校正身高和性别后也与30天生存结局无关。

研究设计与样本

  • 回顾性研究,纳入2015年1月至2019年12月因急性呼吸衰竭需要VV ECMO的全部患者,共189例(年龄43.8±14.6岁,女性42.3%),使用自动图像分割软件量化启动ECMO支持后48小时内全身CT图像上L3水平不同肌肉和脂肪区域的横截面积和平均放射密度(Hounsfield单位),主要终点为启动ECMO后30天全因死亡率,采用逻辑回归分析CT测量值、合并症与30天生存的相关性。

关键影像表现/征象

  • L3水平腰大肌、最长肌和腹部肌肉的肌肉衰减在ECMO插管后30天内死亡者中显著更低(p<0.05)。
  • 30天生存状态与肌肉或脂肪横截面积无显著关联。

诊断标准与关键数值

  • 多变量分析(纳入年龄、性别和既存呼吸系统合并症)显示腰大肌衰减是30天生存的独立预测因子(OR 0.97;95% CI 0.94至1.00;p=0.047)。

临床应用与阅片要点

  • 原文结论指出腰大肌衰减降低与VV ECMO支持呼吸衰竭患者启动ECMO后30天生存结局较差相关。
  • 原文结论指出肌肉和脂肪区域横截面积即使校正身高和性别后也与30天生存结局无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To ascertain the association between body composition, including muscle mass and adiposity, and patient mortality in those requiring extracorporeal membrane oxygenation (ECMO) for acute respiratory failure.

MATERIALS AND METHODS: A retrospective study was undertaken of all patients with acute respiratory failure requiring veno-venous (VV) ECMO between January 2015 and December 2019. Automated image segmentation software was used to quantify the cross-sectional area and average radiodensity (in Hounsfield units) of different muscle and fat compartments at the L3 level of whole-body computed tomography (CT) images taken within 48 h of initiation of ECMO support. The primary endpoint was 30-day post-ECMO initiation all-cause mortality. Logistic regression was used to analyse the correlation between CT measurements, co-morbidities, and 30-day survival.

RESULTS: The study included 189 patients (age = 43.8 ± 14.6, sex = 42.3% female). There was no significant association between 30-day survival status and cross-sectional area of muscle or fat. Muscle attenuation (psoas, long spine, and abdominal muscles respectively) at the L3 level were significantly lower in those who died within 30 days of ECMO cannulation (p<0.05). On multivariable analysis including age, sex, and pre-existing respiratory comorbidities, psoas muscle attenuation was an independent predictor of survival at 30 days (OR 0.97; 95% CI 0.94 to 1.00; p=0.047).

CONCLUSIONS: Reduced psoas muscle attenuation is associated with poorer survival outcomes at 30 days post-ECMO cannulation in patients who received VV ECMO support for respiratory failure. Cross-sectional areas of muscle and fat compartments did not correlate with survival outcomes at 30 days even when corrected for height and sex.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Takenoshita M, Weir McCall JR, Barker AP, et al. Association between body composition and mortality in patients requiring extracorporeal membrane oxygenation support. Clin Radiol. 2024. PMID: 38278741. doi:10.1016/j.crad.2023.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。